Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Oct 3;273(2):10.1016/j.taap.2013.09.021. doi: 10.1016/j.taap.2013.09.021

Figure 6.

Figure 6

A schematic diagram depicting the cytotoxic effects of EGCG on human skin cancer cells by targeting β-catenin signaling through inhibition of PGE2 production, an inflammatory mediator in cancer cells.